Biomarker Tests Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Application (Cancer, Cardiovascular, Infectious Diseases, Central Nervous System, Others); End User (Pharma and Biotech Companies, Diagnostic Companies, Healthcare IT Companies, Clinical Laboratories)
Report Code: TIPRE00017772 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
Biomarker testing is the focus of personalized medicine. The word biomarker refers to the body's molecules that can be measured to assess health. Molecules can be recovered from blood, body fluids, or tissue. Biomarker testing is a collection of tests that scans these molecular signs of health to plan the best care for patients. Biomarker testing may also be called molecular testing or genetic testing..
MARKET DYNAMICS
The Biomarker tests market is driving due to high prevalence of cancer, extensive research and technological advancements used for the development of biomarker and increase in global burden of chronic diseases. Moreover, lack of awareness about the possible applications of biomarkers, stringent regulatory framework, and lack of research and indications are the factors anticipated to impede the market growth.
MARKET SCOPE
The "Biomarker Tests Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biomarker tests market with detailed market segmentation by application and end user. The biomarker tests market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biomarker tests market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biomarker tests market is segmented on the basis of application and end user. Based on application, the market is segmented as with cancer, cardiovascular, infectious diseases, central nervous system, and others. Based on end user, the market is segmented as pharma and biotech companies, diagnostic companies, healthcare it companies, and clinical laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biomarker tests market based on various segments. It also provides market size and forecast estimates from year 2018 t o2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biomarker tests market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biomarker tests market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomarker tests market in these regions.
The report covers key developments in the biomarker tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biomarker tests market are anticipated to have lucrative growth opportunities in the future with the rising demand for biomarker tests in the global market. Below mentioned is the list of few companies engaged in the biomarker tests market.
The report also includes the profiles of key players in biomarker tests market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Biomarker testing is the focus of personalized medicine. The word biomarker refers to the body's molecules that can be measured to assess health. Molecules can be recovered from blood, body fluids, or tissue. Biomarker testing is a collection of tests that scans these molecular signs of health to plan the best care for patients. Biomarker testing may also be called molecular testing or genetic testing..
MARKET DYNAMICS
The Biomarker tests market is driving due to high prevalence of cancer, extensive research and technological advancements used for the development of biomarker and increase in global burden of chronic diseases. Moreover, lack of awareness about the possible applications of biomarkers, stringent regulatory framework, and lack of research and indications are the factors anticipated to impede the market growth.
MARKET SCOPE
The "Biomarker Tests Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biomarker tests market with detailed market segmentation by application and end user. The biomarker tests market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biomarker tests market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biomarker tests market is segmented on the basis of application and end user. Based on application, the market is segmented as with cancer, cardiovascular, infectious diseases, central nervous system, and others. Based on end user, the market is segmented as pharma and biotech companies, diagnostic companies, healthcare it companies, and clinical laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biomarker tests market based on various segments. It also provides market size and forecast estimates from year 2018 t o2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biomarker tests market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biomarker tests market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomarker tests market in these regions.
The report covers key developments in the biomarker tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biomarker tests market are anticipated to have lucrative growth opportunities in the future with the rising demand for biomarker tests in the global market. Below mentioned is the list of few companies engaged in the biomarker tests market.
The report also includes the profiles of key players in biomarker tests market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GLAXOSMITHKLINE PLC
- GE HEALTHCARE
- PFIZER INC.
- NOVARTIS AG
- MEDTRONIC PLC
- F. HOFFMANN-LA ROCHE AG
- QUEST DIAGNOSTICS
- QIAGEN N.V.
- BECTON, DICKINSON
- BIO-RAD LABORATORIES
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biomarker Tests Market - By Application
1.3.2 Biomarker Tests Market - By End User
1.3.3 Biomarker Tests Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOMARKER TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOMARKER TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOMARKER TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOMARKER TESTS - GLOBAL MARKET OVERVIEW
6.2. BIOMARKER TESTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOMARKER TESTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. CARDIOVASCULAR
7.4.1. Overview
7.4.2. Cardiovascular Market Forecast and Analysis
7.5. INFECTIOUS DISEASES
7.5.1. Overview
7.5.2. Infectious Diseases Market Forecast and Analysis
7.6. CENTRAL NERVOUS SYSTEM
7.6.1. Overview
7.6.2. Central Nervous System Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BIOMARKER TESTS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. PHARMA AND BIOTECH COMPANIES
8.3.1. Overview
8.3.2. Pharma and Biotech Companies Market Forecast and Analysis
8.4. DIAGNOSTIC COMPANIES
8.4.1. Overview
8.4.2. Diagnostic Companies Market Forecast and Analysis
8.5. HEALTHCARE IT COMPANIES
8.5.1. Overview
8.5.2. Healthcare IT Companies Market Forecast and Analysis
8.6. CLINICAL LABORATORIES
8.6.1. Overview
8.6.2. Clinical Laboratories Market Forecast and Analysis
9. BIOMARKER TESTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biomarker Tests Market Overview
9.1.2 North America Biomarker Tests Market Forecasts and Analysis
9.1.3 North America Biomarker Tests Market Forecasts and Analysis - By Application
9.1.4 North America Biomarker Tests Market Forecasts and Analysis - By End User
9.1.5 North America Biomarker Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biomarker Tests Market
9.1.5.1.1 United States Biomarker Tests Market by Application
9.1.5.1.2 United States Biomarker Tests Market by End User
9.1.5.2 Canada Biomarker Tests Market
9.1.5.2.1 Canada Biomarker Tests Market by Application
9.1.5.2.2 Canada Biomarker Tests Market by End User
9.1.5.3 Mexico Biomarker Tests Market
9.1.5.3.1 Mexico Biomarker Tests Market by Application
9.1.5.3.2 Mexico Biomarker Tests Market by End User
9.2. EUROPE
9.2.1 Europe Biomarker Tests Market Overview
9.2.2 Europe Biomarker Tests Market Forecasts and Analysis
9.2.3 Europe Biomarker Tests Market Forecasts and Analysis - By Application
9.2.4 Europe Biomarker Tests Market Forecasts and Analysis - By End User
9.2.5 Europe Biomarker Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biomarker Tests Market
9.2.5.1.1 Germany Biomarker Tests Market by Application
9.2.5.1.2 Germany Biomarker Tests Market by End User
9.2.5.2 France Biomarker Tests Market
9.2.5.2.1 France Biomarker Tests Market by Application
9.2.5.2.2 France Biomarker Tests Market by End User
9.2.5.3 Italy Biomarker Tests Market
9.2.5.3.1 Italy Biomarker Tests Market by Application
9.2.5.3.2 Italy Biomarker Tests Market by End User
9.2.5.4 Spain Biomarker Tests Market
9.2.5.4.1 Spain Biomarker Tests Market by Application
9.2.5.4.2 Spain Biomarker Tests Market by End User
9.2.5.5 United Kingdom Biomarker Tests Market
9.2.5.5.1 United Kingdom Biomarker Tests Market by Application
9.2.5.5.2 United Kingdom Biomarker Tests Market by End User
9.2.5.6 Rest of Europe Biomarker Tests Market
9.2.5.6.1 Rest of Europe Biomarker Tests Market by Application
9.2.5.6.2 Rest of Europe Biomarker Tests Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biomarker Tests Market Overview
9.3.2 Asia-Pacific Biomarker Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biomarker Tests Market
9.3.5.1.1 Australia Biomarker Tests Market by Application
9.3.5.1.2 Australia Biomarker Tests Market by End User
9.3.5.2 China Biomarker Tests Market
9.3.5.2.1 China Biomarker Tests Market by Application
9.3.5.2.2 China Biomarker Tests Market by End User
9.3.5.3 India Biomarker Tests Market
9.3.5.3.1 India Biomarker Tests Market by Application
9.3.5.3.2 India Biomarker Tests Market by End User
9.3.5.4 Japan Biomarker Tests Market
9.3.5.4.1 Japan Biomarker Tests Market by Application
9.3.5.4.2 Japan Biomarker Tests Market by End User
9.3.5.5 South Korea Biomarker Tests Market
9.3.5.5.1 South Korea Biomarker Tests Market by Application
9.3.5.5.2 South Korea Biomarker Tests Market by End User
9.3.5.6 Rest of Asia-Pacific Biomarker Tests Market
9.3.5.6.1 Rest of Asia-Pacific Biomarker Tests Market by Application
9.3.5.6.2 Rest of Asia-Pacific Biomarker Tests Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biomarker Tests Market Overview
9.4.2 Middle East and Africa Biomarker Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biomarker Tests Market
9.4.5.1.1 South Africa Biomarker Tests Market by Application
9.4.5.1.2 South Africa Biomarker Tests Market by End User
9.4.5.2 Saudi Arabia Biomarker Tests Market
9.4.5.2.1 Saudi Arabia Biomarker Tests Market by Application
9.4.5.2.2 Saudi Arabia Biomarker Tests Market by End User
9.4.5.3 U.A.E Biomarker Tests Market
9.4.5.3.1 U.A.E Biomarker Tests Market by Application
9.4.5.3.2 U.A.E Biomarker Tests Market by End User
9.4.5.4 Rest of Middle East and Africa Biomarker Tests Market
9.4.5.4.1 Rest of Middle East and Africa Biomarker Tests Market by Application
9.4.5.4.2 Rest of Middle East and Africa Biomarker Tests Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biomarker Tests Market Overview
9.5.2 South and Central America Biomarker Tests Market Forecasts and Analysis
9.5.3 South and Central America Biomarker Tests Market Forecasts and Analysis - By Application
9.5.4 South and Central America Biomarker Tests Market Forecasts and Analysis - By End User
9.5.5 South and Central America Biomarker Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biomarker Tests Market
9.5.5.1.1 Brazil Biomarker Tests Market by Application
9.5.5.1.2 Brazil Biomarker Tests Market by End User
9.5.5.2 Argentina Biomarker Tests Market
9.5.5.2.1 Argentina Biomarker Tests Market by Application
9.5.5.2.2 Argentina Biomarker Tests Market by End User
9.5.5.3 Rest of South and Central America Biomarker Tests Market
9.5.5.3.1 Rest of South and Central America Biomarker Tests Market by Application
9.5.5.3.2 Rest of South and Central America Biomarker Tests Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOMARKER TESTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOMARKER TESTS MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GE HEALTHCARE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. QUEST DIAGNOSTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QIAGEN N.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BECTON, DICKINSON
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biomarker Tests Market - By Application
1.3.2 Biomarker Tests Market - By End User
1.3.3 Biomarker Tests Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOMARKER TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOMARKER TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOMARKER TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOMARKER TESTS - GLOBAL MARKET OVERVIEW
6.2. BIOMARKER TESTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOMARKER TESTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. CARDIOVASCULAR
7.4.1. Overview
7.4.2. Cardiovascular Market Forecast and Analysis
7.5. INFECTIOUS DISEASES
7.5.1. Overview
7.5.2. Infectious Diseases Market Forecast and Analysis
7.6. CENTRAL NERVOUS SYSTEM
7.6.1. Overview
7.6.2. Central Nervous System Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BIOMARKER TESTS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. PHARMA AND BIOTECH COMPANIES
8.3.1. Overview
8.3.2. Pharma and Biotech Companies Market Forecast and Analysis
8.4. DIAGNOSTIC COMPANIES
8.4.1. Overview
8.4.2. Diagnostic Companies Market Forecast and Analysis
8.5. HEALTHCARE IT COMPANIES
8.5.1. Overview
8.5.2. Healthcare IT Companies Market Forecast and Analysis
8.6. CLINICAL LABORATORIES
8.6.1. Overview
8.6.2. Clinical Laboratories Market Forecast and Analysis
9. BIOMARKER TESTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biomarker Tests Market Overview
9.1.2 North America Biomarker Tests Market Forecasts and Analysis
9.1.3 North America Biomarker Tests Market Forecasts and Analysis - By Application
9.1.4 North America Biomarker Tests Market Forecasts and Analysis - By End User
9.1.5 North America Biomarker Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biomarker Tests Market
9.1.5.1.1 United States Biomarker Tests Market by Application
9.1.5.1.2 United States Biomarker Tests Market by End User
9.1.5.2 Canada Biomarker Tests Market
9.1.5.2.1 Canada Biomarker Tests Market by Application
9.1.5.2.2 Canada Biomarker Tests Market by End User
9.1.5.3 Mexico Biomarker Tests Market
9.1.5.3.1 Mexico Biomarker Tests Market by Application
9.1.5.3.2 Mexico Biomarker Tests Market by End User
9.2. EUROPE
9.2.1 Europe Biomarker Tests Market Overview
9.2.2 Europe Biomarker Tests Market Forecasts and Analysis
9.2.3 Europe Biomarker Tests Market Forecasts and Analysis - By Application
9.2.4 Europe Biomarker Tests Market Forecasts and Analysis - By End User
9.2.5 Europe Biomarker Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biomarker Tests Market
9.2.5.1.1 Germany Biomarker Tests Market by Application
9.2.5.1.2 Germany Biomarker Tests Market by End User
9.2.5.2 France Biomarker Tests Market
9.2.5.2.1 France Biomarker Tests Market by Application
9.2.5.2.2 France Biomarker Tests Market by End User
9.2.5.3 Italy Biomarker Tests Market
9.2.5.3.1 Italy Biomarker Tests Market by Application
9.2.5.3.2 Italy Biomarker Tests Market by End User
9.2.5.4 Spain Biomarker Tests Market
9.2.5.4.1 Spain Biomarker Tests Market by Application
9.2.5.4.2 Spain Biomarker Tests Market by End User
9.2.5.5 United Kingdom Biomarker Tests Market
9.2.5.5.1 United Kingdom Biomarker Tests Market by Application
9.2.5.5.2 United Kingdom Biomarker Tests Market by End User
9.2.5.6 Rest of Europe Biomarker Tests Market
9.2.5.6.1 Rest of Europe Biomarker Tests Market by Application
9.2.5.6.2 Rest of Europe Biomarker Tests Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biomarker Tests Market Overview
9.3.2 Asia-Pacific Biomarker Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Biomarker Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biomarker Tests Market
9.3.5.1.1 Australia Biomarker Tests Market by Application
9.3.5.1.2 Australia Biomarker Tests Market by End User
9.3.5.2 China Biomarker Tests Market
9.3.5.2.1 China Biomarker Tests Market by Application
9.3.5.2.2 China Biomarker Tests Market by End User
9.3.5.3 India Biomarker Tests Market
9.3.5.3.1 India Biomarker Tests Market by Application
9.3.5.3.2 India Biomarker Tests Market by End User
9.3.5.4 Japan Biomarker Tests Market
9.3.5.4.1 Japan Biomarker Tests Market by Application
9.3.5.4.2 Japan Biomarker Tests Market by End User
9.3.5.5 South Korea Biomarker Tests Market
9.3.5.5.1 South Korea Biomarker Tests Market by Application
9.3.5.5.2 South Korea Biomarker Tests Market by End User
9.3.5.6 Rest of Asia-Pacific Biomarker Tests Market
9.3.5.6.1 Rest of Asia-Pacific Biomarker Tests Market by Application
9.3.5.6.2 Rest of Asia-Pacific Biomarker Tests Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biomarker Tests Market Overview
9.4.2 Middle East and Africa Biomarker Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Biomarker Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biomarker Tests Market
9.4.5.1.1 South Africa Biomarker Tests Market by Application
9.4.5.1.2 South Africa Biomarker Tests Market by End User
9.4.5.2 Saudi Arabia Biomarker Tests Market
9.4.5.2.1 Saudi Arabia Biomarker Tests Market by Application
9.4.5.2.2 Saudi Arabia Biomarker Tests Market by End User
9.4.5.3 U.A.E Biomarker Tests Market
9.4.5.3.1 U.A.E Biomarker Tests Market by Application
9.4.5.3.2 U.A.E Biomarker Tests Market by End User
9.4.5.4 Rest of Middle East and Africa Biomarker Tests Market
9.4.5.4.1 Rest of Middle East and Africa Biomarker Tests Market by Application
9.4.5.4.2 Rest of Middle East and Africa Biomarker Tests Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biomarker Tests Market Overview
9.5.2 South and Central America Biomarker Tests Market Forecasts and Analysis
9.5.3 South and Central America Biomarker Tests Market Forecasts and Analysis - By Application
9.5.4 South and Central America Biomarker Tests Market Forecasts and Analysis - By End User
9.5.5 South and Central America Biomarker Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biomarker Tests Market
9.5.5.1.1 Brazil Biomarker Tests Market by Application
9.5.5.1.2 Brazil Biomarker Tests Market by End User
9.5.5.2 Argentina Biomarker Tests Market
9.5.5.2.1 Argentina Biomarker Tests Market by Application
9.5.5.2.2 Argentina Biomarker Tests Market by End User
9.5.5.3 Rest of South and Central America Biomarker Tests Market
9.5.5.3.1 Rest of South and Central America Biomarker Tests Market by Application
9.5.5.3.2 Rest of South and Central America Biomarker Tests Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOMARKER TESTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOMARKER TESTS MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GE HEALTHCARE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. QUEST DIAGNOSTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QIAGEN N.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BECTON, DICKINSON
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GLAXOSMITHKLINE PLC
2. GE HEALTHCARE
3. PFIZER INC.
4. NOVARTIS AG
5. MEDTRONIC PLC
6. F. HOFFMANN-LA ROCHE AG
7. QUEST DIAGNOSTICS
8. QIAGEN N.V.
9. BECTON, DICKINSON
10. BIO-RAD LABORATORIES
2. GE HEALTHCARE
3. PFIZER INC.
4. NOVARTIS AG
5. MEDTRONIC PLC
6. F. HOFFMANN-LA ROCHE AG
7. QUEST DIAGNOSTICS
8. QIAGEN N.V.
9. BECTON, DICKINSON
10. BIO-RAD LABORATORIES